Brief Title
Coronary and Structural Interventions - Transcatheter Aortic Valve Replacement
Official Title
Coronary and Structural Interventions - Transcatheter Aortic Valve Replacement
Brief Summary
To evaluate the long-term results after transcatheter aortic valve replacement
Detailed Description
Patients with transcatheter aortic valve replacement are followed for 5 years to demonstrate efficacy and safety.
Study Type
Interventional
Primary Outcome
Major adverse cerebral and cardiac events.
Condition
Aortic Valve Stenosis
Intervention
CE certified transcatheter ( aortic valve replacement)
Study Arms / Comparison Groups
transcatheter aortic valve replacement
Description: Patients receive transcatheter aortic valve replacement.
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Recruitment Status
Device
Estimated Enrollment
843
Start Date
June 2014
Completion Date
December 2018
Primary Completion Date
December 2018
Eligibility Criteria
Inclusion Criteria: - aortic valve stenosis - transcatheter aortic valve replacement Exclusion Criteria: - no written informed consent
Gender
All
Ages
18 Years - N/A
Accepts Healthy Volunteers
No
Contacts
Jochen Wöhrle, MD, ,
Location Countries
Germany
Location Countries
Germany
Administrative Informations
NCT ID
NCT02162069
Organization ID
CSI TAVR 1.0
Responsible Party
Principal Investigator
Study Sponsor
University of Ulm
Study Sponsor
Jochen Wöhrle, MD, Principal Investigator, University of Ulm, Ulm, Germany
Verification Date
April 2020